|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|NVIV||InVivo Therapeutics Hldg||1.09||0.18||20.34%||37.3M|
You can purchase shares of InVivo Therapeutics Hldg (NASDAQ: NVIV) through any online brokerage.
The latest price target for InVivo Therapeutics Hldg (NASDAQ: NVIV) was reported by Raymond James on 2017-05-05. The analyst firm set a price target for 0.00 expecting NVIV to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for InVivo Therapeutics Hldg (NASDAQ: NVIV) is $1.09 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for InVivo Therapeutics Hldg.
There is no upcoming split for InVivo Therapeutics Hldg.